288 related articles for article (PubMed ID: 12228309)
1. Candida-specific antibodies during experimental vaginal candidiasis in mice.
Wozniak KL; Wormley FL; Fidel PL
Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
[TBL] [Abstract][Full Text] [Related]
2. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
[TBL] [Abstract][Full Text] [Related]
3. [IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis].
de Carvalho RJ; Cunha CM; Silva DA; Sopelete MC; Urzedo JE; Moreira TA; Moraes Pde S; Taketomi EA
Rev Assoc Med Bras (1992); 2003; 49(4):434-8. PubMed ID: 14963598
[TBL] [Abstract][Full Text] [Related]
4. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.
Fidel PL; Lynch ME; Conaway DH; Tait L; Sobel JD
Infect Immun; 1995 Feb; 63(2):547-53. PubMed ID: 7822020
[TBL] [Abstract][Full Text] [Related]
5. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1993 May; 61(5):1990-5. PubMed ID: 8097493
[TBL] [Abstract][Full Text] [Related]
6. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis.
Drobacheff C; Millon L; Monod M; Piarroux R; Robinet E; Laurent R; Meillet D
Clin Chem Lab Med; 2001 Jun; 39(6):519-26. PubMed ID: 11506465
[TBL] [Abstract][Full Text] [Related]
7. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1993 Oct; 61(10):4202-7. PubMed ID: 8406809
[TBL] [Abstract][Full Text] [Related]
8. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.
Fidel PL; Lynch ME; Sobel JD
Infect Immun; 1994 Mar; 62(3):1032-8. PubMed ID: 8112837
[TBL] [Abstract][Full Text] [Related]
9. Active and passive immunization against oral Candida albicans infection in a murine model.
Farah CS; Ashman RB
Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis.
Wozniak KL; Palmer G; Kutner R; Fidel PL
Med Mycol; 2005 Nov; 43(7):589-601. PubMed ID: 16396244
[TBL] [Abstract][Full Text] [Related]
11. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections.
Fidel PL; Cutright JL; Sobel JD
Infect Immun; 1995 Oct; 63(10):4191-4. PubMed ID: 7558342
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin classes of human serum antibodies in vaginal candidiasis.
Warnock DW; Milne JD; Fielding AM
Mycopathologia; 1978 Aug; 63(3):173-5. PubMed ID: 357978
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to Candida albicans in human cervicovaginal secretions.
Milne JD; Warnock DW
Br J Vener Dis; 1977 Dec; 53(6):375-8. PubMed ID: 342069
[TBL] [Abstract][Full Text] [Related]
14. Humoral immune responses to Candida albicans complement receptor 3-related protein in the atopic subjects with vulvovaginal candidiasis. Novel sensitive marker for Candida infection.
Paulovičová E; Bujdáková H; Chupáčová J; Paulovičová L; Kertys P; Hrubiško M
FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25673750
[TBL] [Abstract][Full Text] [Related]
15. Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G).
Cárdenas-Freytag L; Steele C; Wormley FL; Cheng E; Clements JD; Fidel PL
Med Mycol; 2002 Jun; 40(3):291-9. PubMed ID: 12146759
[TBL] [Abstract][Full Text] [Related]
16. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.
Fidel PL; Ginsburg KA; Cutright JL; Wolf NA; Leaman D; Dunlap K; Sobel JD
J Infect Dis; 1997 Sep; 176(3):728-39. PubMed ID: 9291322
[TBL] [Abstract][Full Text] [Related]
17. Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta.
Taylor BN; Saavedra M; Fidel PL
Med Mycol; 2000 Dec; 38(6):419-31. PubMed ID: 11204879
[TBL] [Abstract][Full Text] [Related]
18. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.
De Bernardis F; Santoni G; Boccanera M; Lucciarini R; Arancia S; Sandini S; Amantini C; Cassone A
FEMS Yeast Res; 2010 Jun; 10(4):432-40. PubMed ID: 20402794
[TBL] [Abstract][Full Text] [Related]
19. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection.
Cassone A; Boccanera M; Adriani D; Santoni G; De Bernardis F
Infect Immun; 1995 Jul; 63(7):2619-24. PubMed ID: 7790077
[TBL] [Abstract][Full Text] [Related]
20. Multiple experimental designs to evaluate the role of T-cell-mediated immunity against experimental vaginal Candida albicans infection.
Wormley FL; Cutright J; Fidel PL
Med Mycol; 2003 Oct; 41(5):401-9. PubMed ID: 14653516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
